BMRN
Price
$55.93
Change
+$0.41 (+0.74%)
Updated
Nov 28 closing price
Capitalization
10.74B
86 days until earnings call
Intraday BUY SELL Signals
FOLD
Price
$9.93
Change
-$0.09 (-0.90%)
Updated
Nov 28 closing price
Capitalization
3.06B
80 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

BMRN vs FOLD

Header iconBMRN vs FOLD Comparison
Open Charts BMRN vs FOLDBanner chart's image
BioMarin Pharmaceutical
Price$55.93
Change+$0.41 (+0.74%)
Volume$1.2M
Capitalization10.74B
Amicus Therapeutics
Price$9.93
Change-$0.09 (-0.90%)
Volume$1.61M
Capitalization3.06B
BMRN vs FOLD Comparison Chart in %
BMRN
Daily Signal:
Gain/Loss:
FOLD
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
BMRN vs. FOLD commentary
Dec 01, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BMRN is a StrongBuy and FOLD is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 01, 2025
Stock price -- (BMRN: $55.93 vs. FOLD: $9.93)
Brand notoriety: BMRN and FOLD are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BMRN: 43% vs. FOLD: 31%
Market capitalization -- BMRN: $10.74B vs. FOLD: $3.06B
BMRN [@Biotechnology] is valued at $10.74B. FOLD’s [@Biotechnology] market capitalization is $3.06B. The market cap for tickers in the [@Biotechnology] industry ranges from $110.02B to $0. The average market capitalization across the [@Biotechnology] industry is $2.22B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BMRN’s FA Score shows that 0 FA rating(s) are green whileFOLD’s FA Score has 0 green FA rating(s).

  • BMRN’s FA Score: 0 green, 5 red.
  • FOLD’s FA Score: 0 green, 5 red.
According to our system of comparison, FOLD is a better buy in the long-term than BMRN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BMRN’s TA Score shows that 5 TA indicator(s) are bullish while FOLD’s TA Score has 2 bullish TA indicator(s).

  • BMRN’s TA Score: 5 bullish, 2 bearish.
  • FOLD’s TA Score: 2 bullish, 4 bearish.
According to our system of comparison, BMRN is a better buy in the short-term than FOLD.

Price Growth

BMRN (@Biotechnology) experienced а +2.27% price change this week, while FOLD (@Biotechnology) price change was +3.87% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.92%. For the same industry, the average monthly price growth was +1.16%, and the average quarterly price growth was +72.91%.

Reported Earning Dates

BMRN is expected to report earnings on Feb 25, 2026.

FOLD is expected to report earnings on Feb 19, 2026.

Industries' Descriptions

@Biotechnology (+6.92% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BMRN($10.7B) has a higher market cap than FOLD($3.06B). FOLD YTD gains are higher at: 5.414 vs. BMRN (-14.909). BMRN has higher annual earnings (EBITDA): 772M vs. FOLD (33.1M). BMRN has more cash in the bank: 1.48B vs. FOLD (231M). FOLD has less debt than BMRN: FOLD (443M) vs BMRN (604M). BMRN has higher revenues than FOLD: BMRN (3.09B) vs FOLD (571M).
BMRNFOLDBMRN / FOLD
Capitalization10.7B3.06B349%
EBITDA772M33.1M2,332%
Gain YTD-14.9095.414-275%
P/E Ratio20.79N/A-
Revenue3.09B571M542%
Total Cash1.48B231M640%
Total Debt604M443M136%
FUNDAMENTALS RATINGS
BMRN vs FOLD: Fundamental Ratings
BMRN
FOLD
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
68
Overvalued
56
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
7191
PRICE GROWTH RATING
1..100
5740
P/E GROWTH RATING
1..100
92100
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

FOLD's Valuation (56) in the Biotechnology industry is in the same range as BMRN (68). This means that FOLD’s stock grew similarly to BMRN’s over the last 12 months.

FOLD's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as BMRN (100). This means that FOLD’s stock grew similarly to BMRN’s over the last 12 months.

BMRN's SMR Rating (71) in the Biotechnology industry is in the same range as FOLD (91). This means that BMRN’s stock grew similarly to FOLD’s over the last 12 months.

FOLD's Price Growth Rating (40) in the Biotechnology industry is in the same range as BMRN (57). This means that FOLD’s stock grew similarly to BMRN’s over the last 12 months.

BMRN's P/E Growth Rating (92) in the Biotechnology industry is in the same range as FOLD (100). This means that BMRN’s stock grew similarly to FOLD’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BMRNFOLD
RSI
ODDS (%)
N/A
Bearish Trend 3 days ago
75%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
69%
Bearish Trend 3 days ago
81%
Momentum
ODDS (%)
Bullish Trend 3 days ago
58%
N/A
MACD
ODDS (%)
Bullish Trend 3 days ago
57%
N/A
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
56%
Bullish Trend 3 days ago
71%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
53%
Bullish Trend 3 days ago
74%
Advances
ODDS (%)
Bullish Trend 6 days ago
58%
Bullish Trend 7 days ago
69%
Declines
ODDS (%)
Bearish Trend 11 days ago
62%
Bearish Trend 24 days ago
75%
BollingerBands
ODDS (%)
N/A
Bearish Trend 3 days ago
86%
Aroon
ODDS (%)
N/A
Bullish Trend 3 days ago
76%
View a ticker or compare two or three
Interact to see
Advertisement
BMRN
Daily Signal:
Gain/Loss:
FOLD
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
WEEL20.650.12
+0.57%
Peerless Option Income Wheel ETF
LGLV177.650.71
+0.40%
State Street® SPDR®USLrgCapLowVolIdxETF
HYGW30.120.04
+0.13%
iShares High Yld Crp Bd Buywrt Stgy ETF
PPEM27.500.03
+0.09%
Putnam PanAgora ESG Emerg Mkts Eq ETF
IBHL25.850.02
+0.07%
iShares iBonds 2032 Term HY and Inc ETF

FOLD and

Correlation & Price change

A.I.dvisor indicates that over the last year, FOLD has been loosely correlated with BMRN. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if FOLD jumps, then BMRN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FOLD
1D Price
Change %
FOLD100%
-0.90%
BMRN - FOLD
45%
Loosely correlated
+0.74%
RARE - FOLD
44%
Loosely correlated
+2.93%
XNCR - FOLD
44%
Loosely correlated
-0.35%
VCYT - FOLD
43%
Loosely correlated
-0.78%
RGNX - FOLD
42%
Loosely correlated
+0.98%
More